Product Images Venlafaxine Hydrochloride

This is a medication warning label for Venlafaxine Hydrochloride 75mg capsules. The medication is available as a prescription and should be kept out of reach of children. The label lists the medication's lot number and expiration date, as well as its manufacturer and ingredients. Users are advised to contact their doctor for medical advice on possible side effects and to report any side effects to the FDA. The medication should be stored at controlled temperatures between 68-77°F.*

This text appears to be a list of drugs and their potential interactions with other drugs, as well as information on how those interactions may affect the PK Fold Change and 90% CI Recommendation (pharmacokinetics) of the drugs. The list includes drugs such as Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium, and their interactions with the drug Venlafaxine. The text also includes recommendations for dosing and cautionary use with certain patient populations for some of the drugs listed.*

This is a list of drugs with potential interactions and corresponding recommendations based on the change in pharmacokinetic parameters (Cmax and AUC) and the 90% Confidence Interval (CI). The drugs include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The recommendations range from "avoid concomitant use" to "no dose adjustment" but there were some cases where the clinical significance of the interaction was unknown. The list also provides the fold change relative to the reference value for each drug.*

This appears to be a table or chart with information regarding the effects of various conditions on the dosage recommendations for the drug venlafaxine for different patient populations. The conditions listed include hepatic impairment (cirrhosis, mild impairment, moderate impairment), renal impairment (hemodialysis), CYP2D6 polymorphism, age (>60 years), and gender (females/males). The parameters considered for dosage adjustment include Cmax and AUC, and individualization of dosing may be necessary for certain population groups. The chart also includes fold change and 90% confidence intervals for each population group.*